Israeli scientist says COVID-19 could be treated for under $1/day

Israeli scientist says COVID-19 could be treated for under $1/day

Double-blind study shows ivermectin reduces disease’s duration, infectiousness

Share to GabPrint

(JERUSALEM POST) – Ivermectin, a drug used to fight parasites in third-world countries, could help reduce the length of infection for people who contract coronavirus for less than a $1 a day, according to recent research by Sheba Medical Center in Tel Hashomer.

Prof. Eli Schwartz, founder of the Center for Travel Medicine and Tropical Disease at Sheba, conducted a randomized, controlled, double-blinded trial from May 15, 2020, through the end of January 2021 to evaluate the effectiveness of ivermectin in reducing viral shedding among nonhospitalized patients with mild to moderate COVID-19.

Ivermectin has been approved by the US Food and Drug Administration since 1987. The drug’s discoverers were awarded the 2015 Nobel Prize in medicine for its treatment of onchocerciasis, a disease caused by infection with a parasitic roundworm.


Comments

Popular posts from this blog

Lawsuits filed against J&J claim hair loss from shampoo, asbestos in baby powder – should we trust their COVID jab?

Here We Go: Scientists Warn About New Hyper-Infectious South African Variant

Harvard epidemiologist: Major study demolishes case for vaccine passports